Enhanced Liver Fibrosis (ELF) Test
A blood panel combining three markers of extracellular matrix turnover to estimate liver fibrosis — actual scarring, not just enzyme leakage.
ALT and AST tell you about inflammation; they don't tell you about scarring. Someone can have normal enzymes with significant fibrosis. Genuinely important for anyone with fatty liver, heavy alcohol history, or years of oral compound use.
The site previously printed <7.7 as the optimal target with no explanation of which scale that belongs to. Both scales are real and they answer different questions: 7.7 marks the bottom of the fibrosis staging bands, 9.80 and 11.29 mark the prognostic risk bands the US report uses. The ELF score is unitless, so it cannot be sanity-checked against anything — read it against the bands printed on your own report and nothing else.
Check a Enhanced Liver Fibrosis (ELF) Test result against this range →
What Enhanced Liver Fibrosis (ELF) Test actually measures — the analyte, and the assay
The ELF score is not a measurement of your liver. It is an algorithm applied to three measurements of extracellular matrix turnover anywhere in your body. The three analytes are hyaluronic acid, procollagen III amino-terminal peptide and tissue inhibitor of metalloproteinase 1, each measured by immunoassay on one manufacturer's platform and then combined in a proprietary logarithmic discriminant function to give a single unitless number.
Two design facts follow from that and both are load-bearing. First, the score is platform-locked: there is no reference measurement procedure for ELF, no certified reference material, and no way to reproduce the number on another analyzer. Second, none of the three analytes is liver-specific. Hyaluronic acid is synthesized by fibroblasts throughout the body; PIIINP is released wherever type III collagen is being laid down; TIMP-1 regulates matrix turnover generally.
What makes the combination work in liver disease is a second mechanism layered on the first. Hyaluronic acid is cleared by hepatic sinusoidal endothelial cells, so in a scarred liver the same molecule rises for two reasons at once — more is being made and less is being removed. That double sensitivity is why the score performs, and it is also why it is hard to interpret in anyone with a reason for systemic matrix turnover.
The performance is real and it has been quantified. Among 829 patients with nonalcoholic fatty liver disease, mean ELF was 10.1 (SD 1.3) in those with advanced fibrosis against 8.6 (1.0) without, and the area under the receiver operating characteristic curve for identifying advanced fibrosis was 0.81 (95% CI 0.77–0.85) against biopsy and 0.79 (0.75–0.82) against transient elastography Younossi 2021.
Enhanced Liver Fibrosis (ELF) Test: what changes the blood, and what only changes the reading
What changes the score for hepatic reasons:
- Active hepatic fibrogenesis. The intended signal — matrix being laid down, which is a different event from the presence of old scar.
- Reduced hepatic sinusoidal clearance of hyaluronic acid, which rises as architecture is lost and amplifies the signal.
- Active hepatic inflammation, which drives matrix turnover without necessarily meaning permanent scarring — so an ELF drawn during a flare of any hepatitis overstates the fibrosis stage.
What changes the score for reasons that have nothing to do with your liver — and this list is longer than the one above:
- Age. Hyaluronic acid and PIIINP both rise with age in people with normal livers, so an older reader starts higher. This is the single largest non-hepatic term and it is why thresholds validated in one age band travel badly Vali 2025.
- Any systemic inflammatory or fibrotic disease. Rheumatoid arthritis, systemic sclerosis, inflammatory bowel disease and active infection all raise matrix turnover markers.
- Recent food. Serum hyaluronic acid rises postprandially. Draw it fasting, which almost nobody is told.
- Heavy eccentric training and acute muscle remodeling, which is connective-tissue turnover by definition.
- Extrahepatic malignancy and heart failure, both upward.
- Impaired lymphatic drainage, which raises hyaluronic acid.
What changes only the reading: which platform ran it, since there is no harmonization to appeal to; and which threshold set the report applied, which is a reporting choice rather than a measurement Vali 2025.
Reference interval or decision threshold — which kind of number Enhanced Liver Fibrosis (ELF) Test is
Risk bands, not a reference interval — and the bands are not the same in every country or every clinic. Nobody sampled healthy people and took the middle 95%. The published cut-points were chosen to separate patients with advanced fibrosis from patients without, in a particular population, at a particular prevalence.
Which means the threshold depends on who is being tested, and this has now been shown directly. Across a metacohort of 586 patients with metabolic dysfunction-associated steatotic liver disease, diagnostic accuracy varied by subgroup and different thresholds were needed in different subgroups to achieve comparable performance Vali 2025. A single printed cut-off is a simplification of a test whose correct cut-off is a function of your age, your diabetes status and your pre-test probability.
The rule-in and rule-out numbers are worth stating properly, because they are far more useful than a band. In the 829-patient fatty liver cohort, an ELF of 7.2 or greater combined with a FIB-4 of 0.74 or greater gave a negative predictive value of 95.1% (95% CI 91.8–98.4) and a sensitivity of 92.5% (87.4–97.5) — that is the rule-out. An ELF of 9.8 or greater with a FIB-4 of 2.9 or greater gave a positive predictive value of 95.0% (85.5–100) and a specificity of 99.7% (99.1–100) — that is the rule-in Younossi 2021. Note that both are pairs: the sequential use of the free score first and the paid score second is the validated pathway, not ELF alone Kang 2024.
A score of 9.5 is therefore neither reassuring nor alarming on its own. It is a number that needs a FIB-4, an age and a risk profile next to it before it means anything.
How you would know your Enhanced Liver Fibrosis (ELF) Test was wrong — and when to redraw
Twelve months, and the reason is that fibrosis remodels over years. Collagen deposition and resorption in the liver are slow processes; there is no intervention that changes fibrosis stage in six weeks, so a six-week repeat measures analytical noise and the postprandial state, not your liver.
Conditions that must match: fasting, every time, because hyaluronic acid moves after a meal; the same platform; no acute inflammatory illness in the preceding month; no heavy eccentric training in the preceding week; and stable treatment for any systemic inflammatory disease.
What would have to change for the retest to mean something. ELF should move with its neighbors or not at all. The confirmatory set is FIB-4 (which needs only age, ALT, AST and platelets, and is therefore free), platelet count (falling platelets are one of the earliest signs of portal hypertension), and transient elastography. A rising ELF with a stable FIB-4, stable platelets and stable liver stiffness is much more likely to be age, inflammation or extrahepatic matrix turnover than progressing fibrosis Kang 2024 Vali 2025.
How you would know the value was wrong. An isolated raised ELF in someone with no metabolic risk factors, no alcohol history, normal platelets, a low FIB-4 and normal elastography is more likely to be reporting something other than the liver. Before accepting it, check that the sample was fasting, ask what else in the body is remodeling connective tissue, and repeat it rather than escalating to biopsy.
What Enhanced Liver Fibrosis (ELF) Test cannot tell you
It cannot stage fibrosis. It estimates the probability that advanced fibrosis is present. It does not tell you F2 from F3, and the underlying histological stages are ordinal categories that a continuous score approximates rather than reproduces Younossi 2021.
It cannot tell steatohepatitis from bland steatosis. Fat with inflammation and fat without it are different diseases with different trajectories, and ELF does not separate them.
It cannot tell you the cause. Alcohol, metabolic dysfunction, viral hepatitis, autoimmune disease and years of oral 17-alpha-alkylated androgens all produce fibrosis, and all produce the same rising number.
Its positive predictive value collapses in low-prevalence populations. The 95.0% positive predictive value quoted above came from a liver clinic where a quarter of biopsied patients had bridging fibrosis or cirrhosis Younossi 2021. Applied to a healthy gym population where advanced fibrosis is rare, the same cut-off produces mostly false positives — which is arithmetic, not a flaw in the test, and it is the reason the sequential FIB-4-first pathway exists Kang 2024.
A normal ELF does not exclude fibrosis in a high-risk person. The 95.1% negative predictive value is also prevalence-dependent, and in 59 diabetics with normal transaminases 12% still had stage F3 or F4 disease Makker 2021.
The wrong inference readers actually draw is that ELF replaces the liver enzymes because it measures something deeper. It answers a different question, later. The enzymes report current hepatocellular stress — and their reference intervals are themselves set too high Valenti 2021 Choi 2024 Li 2025. ELF reports accumulated matrix change. Someone with an ALT of 45 U/L and an ELF of 8.0 has an active problem and not yet a structural one, and that is precisely the window in which fat loss still reverses it.
Sources read for these sections
- Younossi ZM, et al. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease. JAMA Network Open 2021 · PMID 34529067
- Vali Y, et al. Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD. Liver International 2025 · PMID 39865358
- Kang YW, et al. Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Diagnostics 2024 · PMID 39594183
- Makker J, et al. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study. World Journal of Gastroenterology 2021 · PMID 33642826
- Valenti L, et al. Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update. Hepatology Communications 2021 · PMID 34520121
- Choi J, et al. Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population. Clinical Gastroenterology and Hepatology 2024 · PMID 38750867
- Li Q, et al. Association between De-Ritis ratio (AST/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study. Scientific Reports 2025 · PMID 40113904
Where to start with Enhanced Liver Fibrosis (ELF) Test
In this order. Start at the supplement and you learn nothing, because you never established the number was real.
You have the range, where it came from and the first two moves. Inside is the rest of the five-pathway protocol — supplements, hormones, peptides — the order to run them in, and what to change when the number will not move.
Get the full protocol — $10/mo →📚 NICE guideline NG49 — ELF test for advanced liver fibrosis in NAFLD.
🩸 Test your Enhanced Liver Fibrosis (ELF) Test
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Enhanced Liver Fibrosis (ELF) Test is usually tested alongside
One marker is a data point. These panels add the markers that make Enhanced Liver Fibrosis (ELF) Test interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 7 more markers — Raised liver enzymes on a routine panel, a fatty liver mentioned on a scan, heavy drinking, oral compounds, or metabolic syndrome.
What people use Enhanced Liver Fibrosis (ELF) Test to decide
Nobody orders a test for its own sake. Enhanced Liver Fibrosis (ELF) Test is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
Before assuming toxins, rule out the two inherited causes of liver injury that are common and completely missable: hemochromatosis (iron) and Wilson's disease (copper). Both are one test each.
An ALT above 30 with insulin resistance is fatty liver until proven otherwise, even inside the 'normal' range — the reference range was set on a population that largely had it. The ELF score estimates fibrosis without a biopsy.
Cystatin-C reads kidney function independently of muscle mass, which matters if you're muscular — creatinine systematically overstates decline in that group and understates it in the frail.
A GGT rising with a raised MCV is the classic alcohol pattern and shows up long before anything else does. Thiamine matters most: deficiency causes permanent neurological damage and is trivially preventable.
What moves your Enhanced Liver Fibrosis (ELF) Test
2 supplements in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms Enhanced Liver Fibrosis (ELF) Test helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Enhanced Liver Fibrosis (ELF) Test might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
This is an acute-phase reactant — it moves substantially during any infection, injury or inflammatory episode, and the change has nothing to do with your baseline.
Wait two weeks after any illness, vaccination or injury before drawing or interpreting.
ELF score rises with age independently of fibrosis, so thresholds validated in one age group over-call in older people.
Interpret against an age-aware threshold.
What Enhanced Liver Fibrosis (ELF) Test means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
ELF estimates fibrosis rather than inflammation, which is why it can be abnormal with perfectly normal ALT and AST — enzymes reflect ongoing damage, fibrosis reflects accumulated scarring. But ELF also rises with age independently, so thresholds validated in one age group over-call in older people.
Interpret against an age-aware threshold and alongside imaging. A raised ELF is a hepatology conversation, not a supplement one.
What to test next
These put Enhanced Liver Fibrosis (ELF) Test in context — each with its own full breakdown.
Frequently asked questions
ELF score <7.7 low risk · 7.7–9.8 moderate · ≥9.8 higher risk of advanced fibrosis. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Under 9.80 on the prognostic risk bands US reports use. Under 7.7 is the separate none-to-mild fibrosis staging band. Enhanced Liver Fibrosis (ELF) test information, Labcorp assay documentation.
Suggests significant fibrosis — warrants hepatology evaluation and imaging (FibroScan/elastography).
Reassuring, particularly with normal enzymes.
You can order Enhanced Liver Fibrosis (ELF) Test directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.